ENA RESPIRATORY
Ena Respiratory is a biotechnology company seeking to transform the treatment and prevention of respiratory infections and the effectiveness of vaccines. Ena Respiratory novel, synthetic Toll-like receptor 2 (TLR2) receptor agonists have been shown to activate the innate immune system in the respiratory tract and prevent viral and bacterial dissemination to the lungs.
ENA RESPIRATORY
Industry:
Biotechnology Health Diagnostics Medical
Founded:
2014-01-01
Address:
Melbourne, Victoria, Australia
Country:
Australia
Website Url:
http://www.enarespiratory.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
50 M AUD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Digital Ocean
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Current Advisors List
Current Employees Featured
Founder
Investors List
Brandon Capital Partners
Brandon Capital Partners investment in Venture Round - Ena Respiratory
Uniseed Ventures
Uniseed Ventures investment in Venture Round - Ena Respiratory
Minderoo Foundation
Minderoo Foundation investment in Venture Round - Ena Respiratory
Stoic VC
Stoic VC investment in Venture Round - Ena Respiratory
Ruth Tal-Singer
Ruth Tal-Singer investment in Venture Round - Ena Respiratory
CSL
CSL investment in Series A - Ena Respiratory
AustralianSuper
AustralianSuper investment in Series A - Ena Respiratory
MRCF Biomedical Translation Fund
MRCF Biomedical Translation Fund investment in Series A - Ena Respiratory
Stoic VC
Stoic VC investment in Series A - Ena Respiratory
Uniseed Ventures
Uniseed Ventures investment in Series A - Ena Respiratory
Official Site Inspections
http://www.enarespiratory.com Semrush global rank: 5.92 M Semrush visits lastest month: 1.39 K
- Host name: 172.67.156.12
- IP address: 172.67.156.12
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Ena Respiratory"
Ena Respiratory - Crunchbase Company Profile & Funding
Ena Respiratory is a biotechnology company seeking to transform the treatment and prevention of respiratory infections and the effectiveness of vaccines.See details»
Ena Respiratory | Melbourne Startups
Ena Respiratory is a Melbourne-based biotechnology company focused on developing and commercialising drug therapies for respiratory diseases. The company's primary aim is to …See details»
ENA Respiratory Pty Ltd - VentureRadar
Curida Norway Privately Held Curida is an integrated Contract Development and Manufacturing Organization (CDMO) that specializes in blow-fill-seal (BFS) and nasal spray technologies, as …See details»
Ena Respiratory - News, Partnerships, Locations and Executives
Usearch identified 1 signals for Ena Respiratory, including: 1 Partnerships. Usearch discovered 1 location for Ena Respiratory. Ena Respiratory is headquartered in 31 Queen St L 9. Usearch …See details»
EnaRespiratory | Uniseed
Website: www.enarespiratory.com. ENA Respiratory is a clinical-stage pharmaceutical company developing antiviral host defence enhancers to combat respiratory viral infections by boosting …See details»
Ena Respiratory - Brandon Capital
San Francisco. Brandon Capital LLC. 1 Letterman Ave, Suite C3-330. San Francisco, CA 94129. Phone +61 3 9657 0700. Email: [email protected]See details»
About – ENA Respiratory
ENA Respiratory is a clinical-stage pharmaceutical company. We are tackling symptomatic infections and resulting serious complications (sequelae) of respiratory viral infections through …See details»
ENA Respiratory Profile - highergov.com
Https://enarespiratory.com. Headquarters Melbourne, VICTORIA Australia . Most Recent Award Dec. 8, 2022 ... For Profit Organization Country of Incorporation AUS Employees <500 …See details»
Ena Respiratory - Brandon BioCatalyst
For more information, please visit https://enarespiratory.com. Contact Brandon Biocatalyst is managed by Brandon Capital. Melbourne. Level 9, 31 Queen Street. Melbourne VIC 3000. …See details»
Leadership – ENA Respiratory
Grant Mclachlan, PhD Director, CMC Program Management. Grant joined ENA Respiratory in 2020, overseeing the company’s CMC activities. He brings over 25 years of experience in drug …See details»
News - ENA Respiratory
Apr 2, 2025 ENA Respiratory Publishes Review of Development of Novel Intranasal Antiviral Host Defense Immune Enhancer INNA-051 in Antiviral Research 28 January 2025See details»
ENA Respiratory and the COPD Foundation Partner to Develop …
Feb 23, 2022 For more information, please visit https://enarespiratory.com About The COPD Foundation and COPD360Net The COPD Foundation is a not-for-profit organization …See details»
ENA Respiratory Receives US$5m Investment from Flu Lab to …
Feb 10, 2025 ENA Respiratory’s CEO, Christophe Demaison, PhD said: “There is an urgent need for new approaches to reduce the enormous burden of serious viral respiratory infections …See details»
ENA Respiratory Advances COVID-19 Preventative Therapy
Jun 15, 2021 For more information, please visit https://enarespiratory.com About Brandon Capital Partners Brandon Capital Partners is Australasia’s leading life science venture capital …See details»
ENA Respiratory and the COPD Foundation Partner to Develop …
Feb 23, 2022 For more information, please visit https://enarespiratory.com About The COPD Foundation and COPD360Net The COPD Foundation is a not-for-profit organization …See details»
Flu Lab invests US$5m in Ena Respiratory for INNA-051 - LinkedIn
NEWS Today we are announcing a US$5 million investment from Flu Lab, a California-based organization founded to advance innovative approaches for the prevention and treatment of …See details»
ENA Respiratory Receives US$5m Investment from Flu Lab to …
February 11, 2025. Melbourne, Australia, 10 February 2025 – ENA Respiratory, a clinical-stage pharmaceutical company developing antiviral host defence immune enhancers to minimize the …See details»
ENA Respiratory on LinkedIn: Flu Lab invests US$5m in Ena …
NEWS Today we are announcing a US$5 million investment from Flu Lab, a California-based organization founded to advance innovative approaches for the prevention and treatment of …See details»
ENA Leadership Team | ENA
Guided by ENA's Strategic Plan, the ENA Senior Leadership Team leads the association to achieve its mission and vision in support of the global emergency nursing community.See details»
ENA Respiratory - Samedan
10 February 2025 -- Melbourne, Australia -- ENA Respiratory, a clinical-stage pharmaceutical company developing antiviral host defence immune enhancers to minimize the impact of viral …See details»